Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1) a double-blind, multicentre, randomised trial
E. Magnus Ohman Matthew T Roe; P. Gabriel Steg; Stefan K James; Thomas J Povsic; Jennifer White; Frank Rockhold; Alexei Plotnikov; Hardi Mundl; John Strony; Xiang Sun; Steen Husted; Michal Tendera; Gilles Montalescot; M. Cecilia Bahit; Diego Ardissino; Héctor Bueno; Marc J Claeys; Jose C Nicolau; Jan H Cornel; Shinya Goto; Róbert Gábor Kiss; Ümit Güray; Duk-Woo Park; Christoph Bode; Robert C Welsh; C. Michael Gibson
Lancet London v. 389, n. 10081, p. 1799-1808, 2017London 2017
Acesso online. A biblioteca também possui exemplares impressos.